Agreements reached under this partnership
Business alliance- 1
Supply of cultured supernatant products used as cosmetic raw materials
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
Revenue related to this shipment is scheduled to be recognized upon completion of shipment, and is expected to be recognized in the fourth quarter of the fiscal year ending December 2026 rather than the initially anticipated third quarter.
| Item | Details |
|---|---|
| Name of alliance partner | 株式会社JENECELL |
| Alliance partner's business activities | Develops innovative products using advanced technologies across a wide range of fields, including pharmaceuticals, medical devices and cosmetics based on stem cells. Through its premium cosmetics business based on stem cell culture supernatant, it develops high-performance skincare products and promotes strategic cooperation, in-and-out business and M&A with promising Korean biotechnology and healthcare companies. |
| Alliance partner's location | Seoul, South Korea |
| Type of alliance | Business alliance |
| Details of the alliance | Supply of cultured supernatant products used as cosmetic raw materials |
| Contract Date | Contract concluded as announced on 7 April 2026 |
| Impact on Business Performance | Revenue related to this shipment is scheduled to be recognized upon completion of shipment, and is expected to be recognized in the fourth quarter of the fiscal year ending December 2026 rather than the initially anticipated third quarter. |
Items this document does not state (16)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Logistical procedures were delayed when the completed and prepared products were being transported overseas. No issue occurred in the manufacture of the products.